Award
National Institute of Allergy and Infectious Diseases 1U01AI189441-01
Enhancement of Dose Estimation, Outcome Diagnostics, and Evaluation of Organ Response for Capture's MiRADTM High-Throughput Biodosimetry Assay
Recipient
Capture Collective, Inc.
Award Amount
$449,099.00
Ceiling
$449,099.00
Awarded
May 14, 2026
Identifier
1U01AI189441-01
Capture Collective, Inc. received funding to develop and validate the MiRAD™ assay, a rapid biodosimetry tool for assessing radiation exposure to improve emergency medical response in radiation incidents.
Description
Capture Collective, Inc. is developing a High-Throughput blood-based PCR biodosimetry assay called MiRAD™ to measure individual radiation dose exposure rapidly, supporting efficient medical resource use and improving treatment decisions in radiological or nuclear incidents. The project aims to finalize dose calculation algorithms, verify assay accuracy, and expand diagnostics to develop an FDA-approved biodosimetry solution for mass casualty radiation events.